Symposium to explore future directions for research and treatment

To help set priorities for future research into fibrotic diseases and their treatments, the American Thoracic Society hosted the first “Fibrosis Across Organ Systems” symposium March 8–11 in Denver. More than 60 physicians, academic experts, and patient advocates from such groups as the Hermansky Pudlak Syndrome Network, Coalition for Pulmonary Fibrosis, and Pulmonary Fibrosis Foundation discussed fibrotic diseases of the lung, liver, kidney, heart, and skin. Corporate sponsors included Boehringer Ingelheim, Genentech, InterMune, Gilead Sciences, Sanofi, Celgene, and Stromedix.Continue

	Who's Who at ATS Roberto Accinelli, an ATS World Lung Health Award recipient, makes strides in improving the health of his fellow Peruvians through research and compassionate care. More...		ATS Fellows Corner Scott Manaker and Michael Green talk coding and billing. Learn their strategies for keeping their records accurate and their methods up to date. More...
	Spotlight on Committees Loretta G. Que offers a glimpse inside of the Planning and Evaluation Committee and the crucial role it plays in the Society. More...		The Advocate The Society, NHLBI, and patient groups alert congressional members to the rising burden of pulmonary fibrosis. More...